Works matching DE "BROMOCRIPTINE"

Results: 517

The effects of dopaminergic D₂ stimulation and blockade on smoking behavior.

Published in:

1999

By:

Caskey, Nicholas H.;
Jarvik, Murray E.;
Wirshing, William C.

Publication type:

Journal Article

Dopamine and the structure of personality: Relation of agonist-induced dopamine activity to positive emotionality.

Published in:

1994

By:

Depue, Richard A.;
Luciana, Monica;
Arbisi, Paul;
Collins, Paul;
Leon, Arthur

Publication type:

Journal Article

Feeding induced by ventricular bromocriptine and amphetamine: A possible excitatory role for dopamine in eating behavior.

Published in:

1987

By:

Evans, Kenneth R.;
Eikelboom, Roelof

Publication type:

Journal Article

Kolloid Kist Operasyonuna Bağlı Apatinin Bromokriptin ile Tedavisi: Bir Olgu Sunumu.

Published in:

Klinik Psikofarmakoloji Bulteni, 2007, v. 17, n. 3, p. 138

By:

Ulaş, Halis;
Tunca, Zeliha;
Yıldız, Ayşegül

Publication type:

Article

Different Effects of Cabergoline and Bromocriptine on Metabolic and Cardiovascular Risk Factors in Patients with Elevated Prolactin Levels.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2015, v. 116, n. 3, p. 251, doi. 10.1111/bcpt.12307

By:

Krysiak, Robert;
Okopien, Bogusław

Publication type:

Article

Therapeutic Effect of Bromocriptine as a Dopamine Agonist on Endometrioma Size: A Double-Blind Randomized Controlled Trial.

Published in:

International Journal of Women's Health & Reproduction Sciences, 2025, v. 13, n. 1, p. 25, doi. 10.15296/ijwhr.2023.27

By:

Poordast, Tahere;
Nasir Kandi, Marziyeh Parizad;
Najarkolaei, Elnaz Hosseini;
Askari, Elham;
Khalili, Azizeh Farshbaf

Publication type:

Article

Pharmacologic Management of Central Fever: A Review of Evidence for Bromocriptine, Propranolol, and Baclofen.

Published in:

Journal of Pharmacy Technology, 2023, v. 39, n. 1, p. 29, doi. 10.1177/87551225221132678

By:

Reinert, Justin P.;
Kormanyos, Zsanett

Publication type:

Article

Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism.

Published in:

Life (2075-1729), 2023, v. 13, n. 4, p. 1024, doi. 10.3390/life13041024

By:

Hsu, Chih-Neng;
Hsuan, Chin-Feng;
Liao, Daniel;
Chang, Jack Keng-Jui;
Chang, Allen Jiun-Wei;
Hee, Siow-Wey;
Lee, Hsiao-Lin;
Teng, Sean I. F.

Publication type:

Article

Paroxysmal autonomic nerve dysfunction after severe traumatic brain injury surgery: four cases report and review of literature.

Published in:

Chinese Journal of Contemporary Neurology & Neurosurgery, 2014, v. 14, n. 7, p. 633, doi. 10.3969/j.issn.1672-6731.2014.07.016

By:

LIU Zhao-hui;
LIANG Yuan;
WANG Peng-cheng;
CHEN Jian-nan;
ZHU Wei-lin;
CHENG Tao;
ZHAO Jian-nong

Publication type:

Article

Untreated Giant Macroprolactinoma with Chronic Cerebrospinal Fluid Leakage: An Unusual Complication.

Published in:

Case Reports in Endocrinology, 2019, p. 1, doi. 10.1155/2019/4825357

By:

Mad Naser, Mohamad Nazrulhisham;
Aziz, Nor Azizah;
Karim, Noor Khairiah A.

Publication type:

Article

Open-label pilot study of bupropion plus bromocriptine for treatment of cocaine dependence.

Published in:

2002

By:

Montoya, Ivan D.;
Preston, Kenzie L.;
Rothman, Richard;
Gorelick, David A.

Publication type:

journal article

Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.

Published in:

2004

By:

Sakazume, Satoru;
Obata, Kazuo;
Takahashi, Etsurou;
Yoshino, Atsunori;
Murakami, Nobuyuki;
Sakuta, Ryoich;
Murai, Takayasu;
Nagai, Toshiro

Publication type:

journal article

Selective Carbonylation of Benzene to Benzaldehyde.

Published in:

Catalysis Letters, 2003, v. 87, n. 3/4, p. 225, doi. 10.1023/A:1023459610534

By:

Guang Lan Zhuo;
Xuan Zhen Jiang

Publication type:

Article

Bromocriptine in Diabetes Mellitus - A Review.

Published in:

Asian Student Medical Journal, 2013, v. 13, n. 6, p. 1

By:

Pandita, Aakriti;
Azher, Idrees

Publication type:

Article

Phosphatases are predicted to govern prolactin-mediated JAK–STAT signaling in pancreatic beta cells.

Published in:

Integrative Biology, 2022, v. 14, n. 2, p. 37, doi. 10.1093/intbio/zyac004

By:

Simoni, Ariella D;
Huber, Holly A;
Georgia, Senta K;
Finley, Stacey D

Publication type:

Article

Negative association of pretreatment cigarette use with smoking-induced striatal dopamine release in smokers receiving bupropion treatment.

Published in:

2016

By:

Weinstein, Aviv Malkiel;
Freedman, Nanette;
Greif, Joel;
Yemini, Zipi;
Mishani, Eyal;
London, Edythe;
Chisin, Roland;
Bocher, Moshe

Publication type:

journal article

Ropinirole for the treatment of tremor in early Parkinson's disease.

Published in:

European Journal of Neurology, 2002, v. 9, n. 3, p. 253, doi. 10.1046/j.1468-1331.2002.00392.x

By:

Schrag, A;
Keens, J;
Warner, J

Publication type:

Article

Utilidad de la cabergolina en pacientes portadores de prolactinoma resistentes o intolerantes a bromocriptina.

Published in:

Cirugía y Cirujanos, 2009, v. 77, n. 3, p. 173

By:

Velázquez-Chávez, Francisco Javier;
Tapia-González, María de los Ángeles;
González-Bárcena, David

Publication type:

Article

Conditioned increase of locomotor activity induced by haloperidol.

Published in:

PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0200178

By:

De la Casa, Luis Gonzalo;
Cárcel, Lucía;
Ruiz-Salas, Juan Carlos;
Vicente, Lucía;
Mena, Auxiliadora

Publication type:

Article

The effects of vaginal bromocriptine and dienogest on women with adenomyosis: a clinical study.

Published in:

Middle East Fertility Society Journal, 2024, v. 29, n. 1, p. 1, doi. 10.1186/s43043-024-00213-6

By:

Bahoorzahi, Parvane;
Aminimoghaddam, Soheila;
Derakhshan, Roya;
Hashemi, Neda;
Rokhgireh, Samaneh

Publication type:

Article

Impaired Cardiometabolic Effects of Bromocriptine in Men With Early‐Onset Androgenic Alopecia.

Published in:

Journal of Clinical Pharmacology, 2023, v. 63, n. 3, p. 345, doi. 10.1002/jcph.2163

By:

Krysiak, Robert;
Basiak, Marcin;
Szkróbka, Witold;
Okopień, Bogusław

Publication type:

Article

Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 1, p. 83, doi. 10.1002/jcph.1301

By:

Krysiak, Robert;
Szkróbka, Witold;
Okopień, Bogusław

Publication type:

Article

The role of bromocriptine in the treatment of patients with active rheumatoid arthritis.

Published in:

International Journal of Rheumatic Diseases, 2013, v. 16, n. 6, p. 662, doi. 10.1111/1756-185x.12015

By:

Salesi, Mansour;
Sadeghihaddadzavareh, Somayeh;
Nasri, Peyman;
Namdarigharaghani, Nasrin;
Farajzadegan, Ziba;
Hajalikhani, Mehri

Publication type:

Article

Bromocriptine or cabergoline-induced cerebrospinal fluid rhinorrhea: A life-threatening complication during management of prolactinoma.

Published in:

Journal of Human Reproductive Sciences, 2011, v. 4, n. 2, p. 104, doi. 10.4103/0974-1208.86096

By:

Singh, Pratibha;
Singh, Manish;
Cugati, Goutham;
Singh, Ajai Kumar

Publication type:

Article

Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe.

Published in:

Journal of Human Reproductive Sciences, 2011, v. 4, n. 1, p. 59, doi. 10.4103/0974-1208.82367

By:

Singh, Pratibha;
Singh, Manish;
Cugati, Goutham;
Singh, Ajai Kumar

Publication type:

Article

Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction.

Published in:: Journal of Human Reproductive Sciences, 2010, v. 3, n. 2, p. 85, doi. 10.4103/0974-1208.69342
Publication type:: Article

To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making.

Published in:

Frontiers in Behavioral Neuroscience, 2015, v. 9, p. 1, doi. 10.3389/fnbeh.2015.00336

By:

Hernandez, Giovanni;
Cheer, Joseph F.

Publication type:

Article

Impulsive actions and choices in laboratory animals and humans: effects of high vs. low dopamine states produced by systemic treatments given to neurologically intact subjects.

Published in:

Frontiers in Behavioral Neuroscience, 2014, v. 8, p. 1, doi. 10.3389/fnbeh.2014.00432

By:

D'Amour-Horvat, Valérie;
Leyton, Marco

Publication type:

Article

Serum prolactin levels in postpill amenorrheic patients.

Published in:

1993

By:

Karaman, A.S.;
Uran, B.;
Erler, A.

Publication type:

journal article

Pregnancy despite continued elevation of prolactin levels while on bromergocryptine.

Published in:

1985

By:

Corson, Stephen L.;
Batzer, Frances R.;
Corson, S L;
Batzer, F R

Publication type:

journal article

A study of postpill amenorrhea.

Published in:

1980

By:

Chatterjee, R;
Banerjee, S;
Ghosh, K K;
Chaudhuri, N

Publication type:

journal article

New Treatment Approaches for Acromegaly.

Published in:

Current Medical Literature: Growth, Growth Hormone, & Metabolism, 2008, v. 2, n. 1, p. 1

By:

Colao, Annamaria

Publication type:

Article

Fibrocystic Breast Changes.

Published in:

Radiologic Technology, 2022, v. 93, n. 3, p. 303M

By:

Faguy, Kathryn

Publication type:

Article

Classical dopamine agonists.

Published in:

Journal of Neural Transmission, 2019, v. 126, n. 4, p. 449, doi. 10.1007/s00702-019-01989-y

By:

Horowski, R.;
Löschmann, P.-A.

Publication type:

Article

Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats.

Published in:

Xenobiotica, 2018, v. 48, n. 10, p. 1028, doi. 10.1080/00498254.2017.1390277

By:

Palle, Suresh;
Neerati, Prasad

Publication type:

Article

An Improved Synthesis of PET Dopamine D2 Receptors Radioligand [11C]Raclopride.

Published in:

Synthetic Communications, 2004, v. 34, n. 10, p. 1897, doi. 10.1081/SCC-120034174

By:

Fei, Xiangshu;
Mock, BruceH.;
DeGrado, TimothyR.;
Wang, Ji‐Quan;
Glick‐Wilson, BarbaraE.;
Sullivan, MichaelL.;
Hutchins, GaryD.;
Zheng, Qi‐Huang

Publication type:

Article

Psychiatric side effects of bromocriptine therapy for postpartum galactorrhoea.

Published in:

Journal of the Royal Society of Medicine, 1987, v. 80, n. 6, p. 387, doi. 10.1177/014107688708000620

By:

Kemperman, C. J. F.;
Zwanikken, G. J.

Publication type:

Article

The future of ergot research.

Published in:

Journal of the Royal Society of Medicine, 1984, v. 77, n. 1, p. 5, doi. 10.1177/014107688407700103

By:

Berde, B.

Publication type:

Article

Bromocriptine and acromegaly: therapeutic implications.

Published in:

Journal of the Royal Society of Medicine, 1979, v. 72, n. 8, p. 562, doi. 10.1177/014107687907200804

By:

Brooks, A. P.;
Stephen, P. J.;
Nairn, I. M.;
Strong, J. A.

Publication type:

Article

Treatment of severe cyclical mastalgia.

Published in:

Journal of the Royal Society of Medicine, 1979, v. 72, n. 7, p. 489, doi. 10.1177/014107687907200705

By:

Montgomery, A. C. V.;
Palmer, B. V.;
Biswas, S.;
Monteiro, J. C. M. P.

Publication type:

Article

Initial bromocriptine did not change mortality in early, mild Parkinson disease.

Published in:

ACP Journal Club, 2002, v. 136, n. 3, p. 109, doi. 10.7326/acpjc-2002-136-3-109

By:

Albanese, Alberto

Publication type:

Article

Drug--Specific Responsiveness of Negative Symptoms.

Published in:

International Journal of Psychosocial Rehabilitation, 2005, v. 10, n. 1, p. 42

By:

Shafti, Saeed Shoja;
Rey, Shahre;
Abad, Amin

Publication type:

Article

Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis.

Published in:

Cancer Cell International, 2007, v. 7, p. 1, doi. 10.1186/1475-2867-7-1

By:

Yan-Nian Jiang;
Yi-Hung Li;
Meng-Wei Ke;
Ting-Yu Tseng;
Yueh-Bih Tang;
Mu-Chiou Huang;
Winston Teng-Kuei Cheng;
Yu-Ten Ju

Publication type:

Article

Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1267-0

By:

Hua Gao;
Fei Wang;
Xiaolei Lan;
Chuzhong Li;
Jie Feng;
Jiwei Bai;
Lei Cao;
Songbai Gui;
Lichuan Hong;
Yazhuo Zhang

Publication type:

Article

Conversion from dopamine agonists to pramipexole: An open-label trial in 227 patients with advanced Parkinson’s disease.

Published in:

Journal of Neurology, 2004, v. 251, n. 3, p. 335, doi. 10.1007/s00415-004-0328-0

By:

Linazasoro, G.

Publication type:

Article

Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease : A short commentary.

Published in:

Journal of Neurology, 2003, v. 250, n. 1, p. 97, doi. 10.1007/s00415-003-0938-y

By:

Quinn, N. P.

Publication type:

Article

Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease : A 16-week bromocriptine controlled study.

Published in:

Journal of Neurology, 2003, v. 250, n. 1, p. 90, doi. 10.1007/s00415-003-0937-z

By:

Joo-Hyuk Im;
Jeong-Ho Ha;
In-Sook Cho;
Myoung C. Lee

Publication type:

Article

Levodopa and bromocriptine in hypoxic brain injury.

Published in:

Journal of Neurology, 2002, v. 249, n. 12, p. 1678, doi. 10.1007/s00415-002-0903-1

By:

Debette, Stéphanie;
Kozlowski, Odile;
Steinling, Marc;
Rousseaux, Marc

Publication type:

Article

Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease.

Published in:

Journal of Neurology, 2000, v. 247, n. 11, p. 868

By:

Haapaniemi, Tarja H.;
Kallio, Mika A.;
Korpelainen, Juha T.;
Suominen, Kalervo;
Tolonen, Uolevi;
Sotaniemi, Kyösti A.;
Myllylä, Vilho V.

Publication type:

Article

Pregnancy and treatment outcome in a patient with left ventricular non-compaction.

Published in:

European Journal of Heart Failure, 2013, v. 15, n. 5, p. 592, doi. 10.1093/eurjhf/hft002

By:

Sawant, Rahul D.;
Freeman, Leisa J.;
Stanley, Katherine P.S.;
McKelvey, Alistair

Publication type:

Article